BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27803053)

  • 1. Polymorphisms in microRNA binding sites of mucin genes as predictors of clinical outcome in colorectal cancer patients.
    Vymetalkova V; Pardini B; Rosa F; Jiraskova K; Di Gaetano C; Bendova P; Levy M; Veskrnova V; Buchler T; Vodickova L; Naccarati A; Vodicka P
    Carcinogenesis; 2017 Jan; 38(1):28-39. PubMed ID: 27803053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcome.
    Naccarati A; Rosa F; Vymetalkova V; Barone E; Jiraskova K; Di Gaetano C; Novotny J; Levy M; Vodickova L; Gemignani F; Buchler T; Landi S; Vodicka P; Pardini B
    Oncotarget; 2016 Apr; 7(17):23156-69. PubMed ID: 26735576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
    Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
    Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival.
    Mullany LE; Herrick JS; Wolff RK; Slattery ML
    Genes Chromosomes Cancer; 2017 Apr; 56(4):285-295. PubMed ID: 27859935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variations in microRNA-binding sites of solute carrier transporter genes as predictors of clinical outcome in colorectal cancer.
    Bendova P; Pardini B; Susova S; Rosendorf J; Levy M; Skrobanek P; Buchler T; Kral J; Liska V; Vodickova L; Landi S; Soucek P; Naccarati A; Vodicka P; Vymetalkova V
    Carcinogenesis; 2021 Apr; 42(3):378-394. PubMed ID: 33319241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in microRNA-binding site and prognosis of patients with colorectal cancer.
    Kim JG; Chae YS; Lee SJ; Kang BW; Park JY; Lee EJ; Jeon HS; Park JS; Choi GS
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):35-41. PubMed ID: 25079514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients.
    Pardini B; Rosa F; Naccarati A; Vymetalkova V; Ye Y; Wu X; di Gaetano C; Buchler T; Novotny J; Matullo G; Vodicka P
    Carcinogenesis; 2015 Jan; 36(1):82-6. PubMed ID: 25368035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
    PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding.
    Pardini B; Rosa F; Barone E; Di Gaetano C; Slyskova J; Novotny J; Levy M; Garritano S; Vodickova L; Buchler T; Gemignani F; Landi S; Vodicka P; Naccarati A
    Clin Cancer Res; 2013 Nov; 19(21):6044-56. PubMed ID: 24036853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival.
    Wang D; Liu Q; Ren Y; Zhang Y; Wang X; Liu B
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck.
    Liu H; Gao F; Dahlstrom KR; Li G; Sturgis EM; Zevallos JP; Wei Q; Liu Z
    Tumour Biol; 2016 Jun; 37(6):8057-66. PubMed ID: 26711789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
    Zhu L; Sturgis EM; Zhang H; Lu Z; Tao Y; Wei Q; Li G
    Int J Cancer; 2017 Oct; 141(7):1355-1364. PubMed ID: 28646528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNPs in microRNA-binding sites in the ITGB1 and ITGB3 3'-UTR increase colorectal cancer risk.
    Ye P; Li Z; Jiang H; Liu T
    Cell Biochem Biophys; 2014 Sep; 70(1):601-7. PubMed ID: 24777809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
    Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
    World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Genetic Variation in MicroRNA-binding Site on Susceptibility to Colorectal Cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JS; Choi GS; Kim JG
    Anticancer Res; 2016 Jul; 36(7):3353-61. PubMed ID: 27354594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
    Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
    Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival.
    Lu S; Catalano C; Huhn S; Pardini B; Partu L; Vymetalkova V; Vodickova L; Levy M; Buchler T; Hemminki K; Vodicka P; Försti A
    PLoS One; 2019; 14(5):e0216666. PubMed ID: 31091244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.
    Dzikiewicz-Krawczyk A; Macieja A; Mały E; Januszkiewicz-Lewandowska D; Mosor M; Fichna M; Strauss E; Nowak J
    J Hematol Oncol; 2014 Jun; 7():43. PubMed ID: 24886876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of miRSNPs associated with the risk of multiple myeloma.
    Macauda A; Calvetti D; Maccari G; Hemminki K; Försti A; Goldschmidt H; Weinhold N; Houlston R; Andersen V; Vogel U; Buda G; Varkonyi J; Sureda A; Martinez Lopez J; Watek M; Butrym A; Sarasquete ME; Dudziński M; Jurczyszyn A; Druzd-Sitek A; Kruszewski M; Subocz E; Petrini M; Iskierka-Jażdżewska E; Raźny M; Szombath G; Marques H; Zawirska D; Chraniuk D; Halka J; Hove Jacobsen SE; Mazur G; García Sanz R; Dumontet C; Moreno V; Stępień A; Beider K; Pelosini M; Manuel Reis R; Krawczyk-Kulis M; Rymko M; Avet-Loiseau H; Lesueur F; Grząśko N; Ostrovsky O; Jamroziak K; Vangsted AJ; Jerez A; Tomczak W; Zaucha JM; Kadar K; Sainz J; Nagler A; Landi S; Gemignani F; Canzian F
    Int J Cancer; 2017 Feb; 140(3):526-534. PubMed ID: 27718532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polymorphisms of miRNA-binding site in MLH3 and ERCC1 were linked to the risk of colorectal cancer in a case-control study.
    Zhang Q; Zheng X; Li X; Sun D; Xue P; Zhang G; Xiao M; Cai Y; Jin C; Yang J; Wu S; Lu X
    Cancer Med; 2018 Apr; 7(4):1264-1274. PubMed ID: 29516665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.